Brief: Plus Therapeutics Announces Pricing Of Upsized $15 Million Public Offering
14/01/2026 13:23
Jan 14 (Reuters) - Plus Therapeutics Inc PSTV.O: PLUS THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $15 MILLION PUBLIC OFFERING PLUS THERAPEUTICS INC - EACH UNIT SOLD AT $0.38, GROSS PROCEEDS EXPECTED $15 MILLION Source text: ID:nGNX57vp4 Further company coverage: PSTV.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerenome
See all newsBrief: Cerenome Secures In-Network Agreement With Florida Blue For Cnside® Csf Tumor Cell Enumeration And Molecular Profile Tests
Plus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Cerenome Secures In-Network Agreement With Health Care Service Corporation
Plus Therapeutics Inc expected to post a loss of 91 cents a share - Earnings Preview
Brief: Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual For CNSide Cerebrospinal Fluid Assay For Metastatic CNS Cancer